But now the tables have turned, and the FDA is more likely to approve or clear novel medical devices before their European counterparts.
“Where we were 10 years ago is not where we are today,” said Jennifer McCaney, the executive director of UCLA Biodesign at DeviceTalks West.
McCaney collaborated wi…